Booster shots necessary to beat COVID-19 virus, says Dr Fauci
Pfizer made the proposal in a 52-page presentation to the US FDA, which included data from the recent Israeli study, which showed…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
New England Journal of Medicine
Study reveals distinct features of deceased COVID-19 patients’ lungs
The researchers speculate that the greater degree of clot formation and blood vessel generation in COVID-19 patients may have…
Takeda’s dengue vaccine candidate demonstrates protection in children aged four to 16 years,…
Takeda’s dengue vaccine candidate was generally well-tolerated, and no important safety risks have been observed to date
Novartis’ two major trials shows significant efficacy of Cosentyx in ankylosing spondylitis…
The study enrolled anti-TNF naïve patients and patients who had previously failed anti-TNF therapy, with clinical benefits…
Sanofi Pasteur’s vaccine candidate protects pre-adolescents to adults against dengue
Based on the clinical profile in nine years of age and older, the dengue vaccine candidate has the potential to significantly…